The assumption was that whatever the risks of legalizing therapeutic MDMA, the crisis of PTSD gripping the country (and doing ...

Federal health officials have declined to approve the psychedelic drug MDMA as a therapy for PTSD. Drugmaker Lykos ...

Drugmaker Lykos Therapeutics had asked the FDA to approve its MDMA capsules as part of a therapy regimen they argued could be a breakthrough for treating challenging cases of PTSD. Lykos said the ...

The US Food and Drug Administration's (FDA) decision not to approve midomafetamine-assisted therapy (MDMA-AT) for ...

Lykos Therapeutics filed an application for FDA approval of its version of MDMA-assisted therapy for PTSD in February 2024.

In June, the FDA's Psychopharmacologic Drugs Advisory Committeevoted 9-2 against MDMA as an effective treatment for PTSD patients, and 10-1 that the drug's benefits do not outweigh the risks.

A Food and Drug Administration (FDA) advisory panel overwhelmingly rejected MDMA-assisted therapy for treating post-traumatic ...

A panel of independent advisers for the FDA recommended against approval ... ketamine magic mushrooms and MDMA, may help treat PTSD and other mental health disorders. Some psychiatrists began ...

The Food and Drug Administration declined Friday to approve an application to treat post-traumatic stress disorder using the ...

MDMA research has been widely publicized by combat veterans, who say limited PTSD treatment options have contributed to ...